Epithelial cell turnover, p53 and bcl-2 protein expression during oncogenesis of early and advanced gastric cancer in a Western population

Digestive and Liver Disease

Volumn 40, Issue 1, 2008, Pages 39-45

  Triantafyllou, K ^a   Kitsanta, P ^b   Karamanolis, D G ^c   Kittas, C ^d   Ladas, S D ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Advanced gastric cancer; Bcl 2; Cell kinetics; Early gastric cancer; p53

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY; PROTEIN BCL 2; PROTEIN P53;

ADVANCED CANCER; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL LABELING; CELL PROLIFERATION; CONTROLLED STUDY; DYSPLASIA; EARLY CANCER; EPITHELIUM CELL; GREECE; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE TUMOR; MAJOR CLINICAL STUDY; NICK END LABELING; POPULATION RESEARCH; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH MUCOSA;

APOPTOSIS; CARCINOMA; CELL PROLIFERATION; EPITHELIAL CELLS; GREECE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MORBIDITY; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS C-BCL-2; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 37149052800     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2007.09.010     Document Type: Article

References (32)

1. Everett A.S., and Axon A.T.R. Early gastric cancer in Europe. Gut 41 (1997) 142-150
2. Ishida M., Gomyo Y., Tatebe S., Ohfujin S., and Ito H. Apoptosis in human gastric mucosa, chronic gastritis, dysplasia and carcinoma: Analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. Virchows Arch 428 (1996) 229-235
3. Lauwers G.Y., Scott G.V., and Hendricks J. Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia. Cancer 73 (1994) 2900-2904
4. Nakamura T., Nomura S., Sakai T., and Nariya S. Expression of bcl-2 oncoprotein in gastrointestinal and uterine carcinomas and their premalignant lesions. Hum Pathol 28 (1997) 309-315
5. Cho J.-H., and Kim W.H. Altered topographic expression of p21WAF1/CIP1/SDI1, bcl2 and p53 during gastric carcinogenesis. Pathol Res Pract 194 (1998) 309-317
6. Gomyo Y., Osaki M., Kaibara N., and Ito H. Numerical aberration and point mutation of p53 gene in human gastric intestinal metaplasia and well-differentiated adenocarcinoma: analysis by fluorescence in situ hybridization (FISH) and PCR-SSCP. Int J Cancer 66 (1996) 594-599
7. Triantafillou N.G., Grosman I.M., and Verma R.S. Genomania of p53 protein in gastric cancer. J Clin Gastroenterol 22 (1996) 170-173
8. Feng C.W., Wang L.D., Jiao L.H., Liu B., Zheng S., and Xie X.J. Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features. BMC Cancer 2 (2002) 8
9. Ishii H.H., Gobe G.C., Pan W., Yoneyama J., and Ebihara Y. Apoptosis and cell proliferation in the development of gastric carcinomas: associations with c-myc and p53 protein expression. J Gastroenterol Hepatol 17 (2002) 966-972
10. Shinohara T., Ohshima K., Murayama H., Kikuchi M., Yamashita Y., and Shirakusa T. Apoptosis and proliferation in gastric carcinoma: the association with histological type. Histopathology 29 (1996) 123-129
11. Ikeda M., Shomori K., Endo K., Makino T., Matsura T., and Ito H. Frequent occurrence of apoptosis is an early event in the oncogenesis of human gastric carcinoma. Virchows Arch 432 (1998) 43-47
12. Xia Ηua-Xiang H., and Talley N.J. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol 96 (2001) 16-26
13. Yoshimura T., Shimoyama T., Tanaka M., Sasaki Y., Fukuda S., and Munakata A. Gastric mucosa inflammation and epithelial cell turnover are associated with gastric cancer in patients with Helicobacter pylori infection. J Clin Pathol 53 (2000) 532-536
14. Pan W., Ishii H., Ebihara Y., and Gobe G. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins. J Surg Oncol 82 (2003) 104-110
15. Vindigni C., Miracco C., Spina D., Presenti L., Galorini M., Vatti R., et al. Cell proliferation, cell death and angiogenesis in early and advanced cancer of intestinal type. Int J Cancer 74 (1997) 637-641
16. Rokkas T., Ladas S., Liatsos C., Petridou E., Papatheodorou G., Theocharis S., et al. Relationship of Helicobacter pylori cagA status to gastric cell proliferation and apoptosis. Dig Dis Sci 44 (1999) 487-493
17. Scotiniotis I.A., Rokkas T., Furth E.E., Rigas B., and Shiff S.J. Altered gastric epithelial cell kinetics in Helicobacter pylori-associated intestinal metaplasia: implications for gastric carcinogenesis. Int J Cancer 85 (2000) 192-200
18. Sougioultzis S., Foukas P.G., Tzivras M., Kourtessa D., Gorgoulis V.G., Davaris P., et al. Alteration in the proliferating compartment of gastric mucosa during Helicobacter pylori infection: the putative role of epithelial cells expressing p27(kip1). Mod Pathol 16 (2003) 1076-1085
19. Japanese Gastric Cancer association, Japanese classification of gastric carcinoma, 2nd English edition, Gastric Cancer 1998; 1:10-24.
20. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histolclinical classification. Acta Pathol Microbiol Scand 64 (1965) 31-49
21. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20:1161-81.
22. Filipe M.I., and Jass J.R. Intestinal metaplasia subtypes and cancer risk. In: Filipe M.I., and Jass J.R. (Eds). Gastric carcinoma (1986), Churchill Livingstone, Edinburgh 97-115
23. Kitsanta P., Triantafyllou K., Chatziargyriou M., Barbatzas C., and Ladas S.D. Gastric mucosa epithelial cell kinetics are differentiated by anatomic site and Helicobacter pylori infection. Dig Dis Sci 50 (2005) 1087-1091
24. Tsukuma H., Oshima A., Narahara H., and Morii T. Natural history of early gastric cancer: a non-concurrent, long term, follow up study. Gut 47 (2000) 618-621
25. Davis P.A., and Sano T. The difference in gastric cancer between Japan, USA and Europe: What are the facts? What are the suggestions?. Crit Rev Oncol Hematol 40 (2001) 77-94
26. Fenoglio-Preiser C.M., Wang J., Stemmermann G.N., and Noffsinger A. TP53 and gastric carcinoma: a review. Hum Mut 21 (2003) 258-270
27. Shiao Y.-H., Rugge M., Correa P., and Lehmann H.P. Scheer WD. p53 alteration in gastric precancerous lesions. Am J Pathol 144 (1994) 511-517
28. Lee K.E., Lee H.-J., Kim Y.H., Yu H.J., Yang H.-K., Kim W.-H., et al. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer. Jpn J Clin Oncol 33 (2003) 173-179
29. Yamada Y., Yoshida T., Hayashi K., Sekiya T., Yokota J., Hirohashi S., et al. p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases. Cancer Res 51 (1991) 5800-5805
30. Ochiai A., Yamauchi Y., and Hirohasi S. p53 mutations in the non-neoplastic mucosa of the human stomach showing intestinal metaplasia. Int J Cancer 69 (1996) 28-33
31. Yamamoto M., Maehara Y., Sakaguchi Y., Kusumoto T., Ichiyoshi Y., and Sugimachi K. Transforming growth factor beta-1 induces apoptosis in gastric cancer cells through a p53-independent pathway. Cancer 77 Suppl 8 (1996) 1628-1633
32. Kasagi N., Gomyo Y., Shirai H., Tsujitani S., and Ito H. Apoptotic cell death in human gastric carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. Jpn J Cancer Res 85 (1994) 939-945